Home
About Us
Products
Product Catalogue
Facilities
Investor
Notice
Annual Report & Audited Accounts
New Annual Report & Audited Accounts
Half Yearly Reports
Quarterly Reports
First Quarter Accounts ended Sep. 30, 2025
Price Sensitive Information (PSI)
Code of Conduct
Dividend Compliance Report
Dividend Disbursement Policy
Unpaid/Unclaimed Dividend
Prospectus
TT clean rate
Utilization Report
Global Operations
Contact Us
Select Page
Ketorolac Trometamol
Category:
By Generic Name
Description
Description
Related products
Erythromycin Ethyl Succinate
Baclofen
Cefixime Trihydrate
